Related Experiment Video
Updated: Jan 17, 2026
09:00
Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
3.7K
Protein aggregation in neurodegenerative diseases.
Jiannan Wang1, Lijun Dai2, Zhentao Zhang1
1Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Chinese Medical Journal
|September 17, 2025
Summary
Neurodegenerative diseases involve progressive neuron loss due to pathological protein aggregates like amyloid-β and tau. Understanding their aggregation and spread is key to developing diagnostics and treatments for conditions such as Alzheimer's and Parkinson's.
Area of Science:
- Neurology
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases are chronic disorders defined by progressive neuron loss.
- Key conditions include Alzheimer's, Parkinson's, Huntington's, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis.
- Pathological hallmarks include the accumulation of protein aggregates like amyloid-β, tau, α-synuclein, and TAR DNA-binding protein 43.
Purpose of the Study:
- To elucidate the molecular mechanisms of pathological protein aggregation and transmission.
- To understand how these aggregates trigger neurodegeneration.
- To review current diagnostic and therapeutic strategies targeting these protein aggregates.
Main Methods:
- Literature review summarizing current research on protein aggregation in neurodegenerative diseases.
- Analysis of molecular pathways involved in protein misfolding, aggregation, and propagation.
- Overview of diagnostic tools and therapeutic interventions.
Main Results:
- Pathological proteins form amyloid fibrils that propagate in a prion-like manner, leading to neurodegeneration.
- Interactions between different pathological proteins can influence disease progression.
- Current research focuses on understanding these mechanisms for therapeutic development.
Conclusions:
- Understanding protein aggregate biology is fundamental to neurodegenerative disease research.
- Targeting pathological protein aggregation offers potential therapeutic avenues.
- Further research is needed to refine diagnostic and therapeutic strategies.
Related Concept Videos
03:03Amyloid Fibrils
11.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.7K
03:03Amyloid Fibrils
6.3K
6.3K
01:37Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K